Receptors for human, simian, ovine, bovine and murine prolactin, human growth hormone and human placental lactogen have been identified in plasma-membrane-containing subcellular particles isolated from rabbit mammary glands. The association and dissociation of '25l-labelled prolactin are time-and temperature-dependent processes, both being maximal at 37°C. 125I-labelled prolactin prepared by the enzymic iodination procedure with lactoperoxidase binds better to receptors than does the preparation obtained by using chloramine-T as the oxidizing agent. The binding of 125I-labelled prolactin to receptors is strongly influenced by pH and ionic composition but not by many low-molecular-weight compounds tested, e.g. steroids, nucleotides and several drugs. Receptor activity is sensitive to trypsin and phospholipase C digestion, suggesting that protein and phospholipid moieties are essential for the binding of 125I-labelled prolactin. The binding of 1251_ labelled prolactin to receptors is a saturable and reversible process. Scatchard and Lineweaver-Burk analyses suggest that 1251-labelled prolactin has a high affinity for its receptor. Binding of 125I-labelled prolactin to receptors does not result in the destruction of the hormone. Considerable prolactin-binding activity is also observed in subcellular fractions isolated from the adrenal gland, liver, ovary and kidney of the pregnant rabbit, a finding that is consistent with other reported actions of prolactin in these organs.
It is generally accepted that in mammals one of the principal target tissues for prolactin is the mammary gland. The direct effects and the mechanism of action of prolactin on mammary growth, differentiation and function have been examined extensively (Cowie & Tindal, 1971) . Turkington (1970) reported that prolactin covalently linked to Sepharose beads is biologically active on mouse mammary epithelial cells and he suggested that prolactin initiates its effect by an action on the cell membrane because it is presumed that the Sepharose-prolactin complexes do not enter the cells. Falconer (1972) and Birkinshaw & Falconer (1972) have demonstrated that 125I-labelled ovine prolactin binds to rabbit mammary tissue in vitro and in vivo and their radioautographic studies showed that the 125I-labelled prolactin that is associated with the epithelial cells is localized on the surface of the cell adjacent to capillaries. Further, Turkington (1971) has reported that 125I-labelled prolactin binds to membrane preparations isolated from cultured mammary tissue obtained from midpregnant mice. However, the limited amount of tissue that can be obtained from this source precludes extensive studies on the properties of the prolactinbinding sites, operationally termed 'receptors'. In a preliminary communication we have reported on the identification of a prolactin receptor in a particular preparation isolated from the mammary glands of neuraminidase (Cl. perfringens) were obtained from Sigma. All nucleotides were from Sigma. 2-Bromo-aergocryptine (CB 154), a product of Sandoz Ltd., Basle, Switzerland, was generously provided by Dr. E. del Pozo (Sandoz). Na125I (carrier-free) was purchased from New England Nuclear, Boston, Mass., U.S. A. H202 (30 %,v/v, solution) was obtained from Fisher Scientific, Fair Lawn, N.J., U.S.A. All other reagents and chemicals were reagent grade.
Sephadex was purchased from Pharmacia, Uppsala, Sweden. New Zealand White rabbits were supplied by Fauna Breeding Laboratory, Montreal, Que., Canada.
Preparation ofprolactin-binding subcellularparticles
Initially, mid-pregnant rabbits (days 15-19) were injected intramuscularly with 10mg of human placental lactogen and 5mg of cortisone daily for 4 days to give maximal stimulation of their mammary glands (Friesen, 1966) , and mammary glands dissected from these hormone-primed rabbits were used as the starting materials for the preparation ofreceptor particles. However, subsequently it became apparent that mammary tissues obtained from pregnant rabbits 1 or 2 days before delivery or from rabbits in early lactation possess similar prolactin-binding characteristics. TIherefore some experiments were carried out by using membrane particles isolated from mammary glands obtained from this group of rabbits. Further procedures for isolation of crude membrane particles and purified plasma membranes that bind 1251. labelled prolactin have been reported (Shiu et al., 1973) . It is worthwhile, however, to mention that the homogenization ofthe mammary tissue can be carried out in a Polytron homogenizer (Brinkmann) type PT 10 (1min at full speed).
Enzyme assay 5'-Nucleotidase activity was assayed as described by Widnell & Unkeless (1968) , except that trichloroacetic acid was used to precipitate particulate protein and the supernatant was assayed for P. Moreover, 10uM-sodium-potassium tartrate was used in the assay incubation to inhibit acid phosphatase activity (El-Aaser & Reid, 1965) . One unit of enzyme activity is defined as the activity that liberates lpmol of Pi from AMP/min. Preparation of labelled hormone Human and ovine prolactin and human growth hormone were iodinated at room temperature by using a procedure similar to that of Thorell & Johansson (1971) involving lactoperoxidase and H202, except that the reaction was allowed to proceed for 1 min. Iodinated hormones were also prepared by the method of Hunter & Greenwood (1962) by using chloramine-T as the oxidizing agent. To remove unreacted 1-and damaged hormone, the mixture was fractionated on a column (1 .5cm x 50cm) of Sephadex G-100 previously equilibrated with Tris-HCl buffer (0.025M; pH7.6). Generally three radioactive peaks were observed. The radioactive material that was eluted in the void volume represented damaged and aggregated hormone. This material was discarded because it did not bind to receptors when subsequently tested. The radioactive material that was eluted from the column at a position where the native hormone appears was used for all binding studies. This material generally shows superior binding to receptors (see the Results section) and normally 70-90% can be precipitated by excess of antibodies. The third radioactive peak represented free 1I-.
The specific radioactivity of the labelled hormone was determined as follows. After the reaction had been stopped, 5u1 of the iodination mixture was taken out and diluted with Tris-HCl buffer, pH7.6, containing 0.1 % (w/v) bovine serum albumin such that 1 ml of the diluted mixture gives about 50000c.p.m. Duplicate samples were used as a routine. Then 2ml of cold 10% (w/v) trichloroacetic acid was added to give a final concentration of about 7 % trichloroacetic acid. The tubes were mixed and then left at 4°C for 1 h before centrifugation at 750g for 10min. The radioactivity that was precipitated by trichloroacetic acid was assumed to be associated with the protein hormone and the trichloroacetic acid-soluble radioactivity was assumed to represent free I-. The percentage of radioactivity incorporated into the hormone was thus obtained. By knowing the amount of hormone and Na125I used, as well as the counting efficiency, the specific radioactivity of the iodinated hormone could be calculated. The specific radioactivity of 'l25-labelled prolactin obtained by using the lactoperoxidase method was generally between 60 and 120uCi/,ug, and that obtained by using chloramine-T was about 100-150OuCi/,ug.
Procedure for testing prolactin-binding activity
The procedure was similar to that described previously (Shiu et al., 1973) . The crude membrane fraction was used in all the studies unless otherwise noted. It was subsequently found, however, that the binding of '25I-labelled prolactin to receptors reaches equilibrium after 5h of incubation at 23°C (see Fig. 2 ). Therefore at room temperature a 6h incubation period was used in this study instead of the 90min incubation period as reported previously (Shiu et al., 1973) . Representative experiments that had been carried out with an incubation period of 90min at room temperature were subsequently repeated by using the longer incubation period. Essentially identical results were obtained. In experiments where only specific binding of '25I-labelled prolactin was required, determinations of binding were carried out in duplicate, and for each determination another set of 1974 duplicate tubes was set up in the presence of 2,ug of unlabelled ovine prolactin (25i.u./mg)/m1 of incubation medium. In the absence of unlabelled prolactin, 10-20% of the labelled hormone added to the medium was bound, whereas in the presence of unlabelled prolactin, 80% less binding was observed.
The difference between the two represents specific binding of '25I-labelled prolactin.
Results

Specificity ofbinding ofprolactin to receptors
We have previously shown that human prolactin as well as prolactin obtained from several other species inhibits the binding of 125I-labelled human prolactin to crude membrane fractions obtained from the rabbit mammary gland and that the ability of prolactin preparations to inhibit the binding of 251I-labelled prolactin is related to the biological potencies of these preparations (Shiu et al., 1973) . Fig. 1 shows that the binding of'251-labelled human prolactin to a 'purified' plasma-membrane fraction has the same characteristics as those demonstrated for the crude membrane fraction. It has also been demonstrated (not shown in Figure) that when 125I-labelled human growth hormone is used as the tracer, purified prolactin (25-30i.u./mg) can inhibit the binding of 125I-labelled human growth hormone to receptors to the same extent as purified human growth hormone. Similarly, 125I-labelled ovine prolactin can also be used instead of 125I-labelled human prolactin.
Effects oftime and temperature on the binding and dissociation ofprolactin
The binding of 1251-labelled ovine prolactin is timeand temperature-dependent (Fig. 2) . At 37°C, equilibrium is attained after about 3h incubation. However, at 23°C (room temperature), specific binding levels off at 5h. Although the rate of association at 37°C is faster than that at 23°C, the maximal binding that can be achieved at either temperature is similar provided that the incubation period at 23°C is prolonged. The binding at 0°C is small.
The dissociation of bound 125I-labelled ovine prolactin is also time-and temperature-dependent (Fig.  3) . Even after 45h the amount of bound 251I-labelled ovine prolactin that is dissociated at 4°C is not greater than 10%. At 23°C it takes 45h to attain 50% dissociation. The rate of dissociation is much faster at 37°C, about 50% of the bound hormone being dissociated from the receptors within 5h.
Effect of the iodination procedure on the binding of 125I-labelledprolactin to receptors Fig. 4 Meldolesi et al. (1971) . Procedures for determining binding of 125I-labelled prolactin have been described previously (Shiu et al., 1973) . The human prolactin used has a potency of 30.5i.u./mg (Frantz et al., 1972a Time of incubation (min) Time (h) Fig. 3 . Effect of time and temperature on dissociation of I251-labelled ovine prolactin from receptors Membrane fractions were incubated at 23°C for 6h in the presence or absence of 2 pg of ovine prolactin/ml and specific binding thus determined was taken as the zerotime value. Another series oftubes that had been incubated in the same fashion were divided into three sets at the end of the 6h period. Then 0.5 ml of a solution containing 5,ug of ovine prolactin was added to each tube. Each set was incubated at the temperature indicated: o, 4°C; 0, 23°C; A, 37°C. Four tubes from each set were taken out at the time-intervals indicated, and specific binding was determined. Two of the four tubes had been incubated in the presence of, and two in the absence of, ovine prolactin during the first 6h of incubation. The former two tubes were included in the dissociation experiment to compensate for any increase in non-specific binding, especially after long periods of incubation. prolactin to receptors Determination of specific binding is described in the Materials and Methods section. Buffers used were: pH4.0-6.5, 0.1 M-sodium acetate-acetic acid; pH7.3, 0.1 M-sodium phosphate; pH7.5-8.4, 0.1 M-Tris-HCI; pH9.9, 0.1 M-Na2CO3-NaHCO3. All pH values are the final pH in the incubation media. All buffers contained lOmM-MgCl2 to eliminate the effect of ionic differences in the buffers. membrane particles was due to non-specific binding. Therefore the 125I-labelled prolactin (human or ovine) used in the present study was prepared by the lactoperoxidase method. Hunter & Greenwood (1962) .
Effect ofpHon binding ofprolactin to receptors
The specific binding of '25I-labelled human prolactin to receptors occurs over a relatively narrow pH range. Maximal binding occurs at pH3.7 (Fig. 5) The binding of 125I-labelled human prolactin to receptors increases linearly with the amount of receptor protein added (Fig. 6 ). Normally 200-400,ug ofmembrane protein is used per incubation and under these conditions 10-20% of 125I-labelled prolactin is bound.
Effect of 125I-labelledprolactin concentration
The specific binding of 125I-labelled ovine prolactin to receptor particles is a saturable process with respect to prolactin (Fig. 7) . Complete saturation, however, is theoretically never reached, as shown in Fig. 7 , unless the amount of 125I-labelled ovine prolactin used reaches infinity. However, a Lineweaver-Burk (Lineweaver & Burk, 1934) plot (Fig. 8a) can be constructed from the data shown in Fig. 7 prolactin in the medium at which half-maximal saturation occurs, is 3.4x10-10M, or about 8ng/ml. This is equal to the physiological concentration of prolactin frequently found in serum. The value is near that found in serum of normal subjects and is consistent with the view that small deviations from this value could result in significant metabolic alterations. A Scatchard (1949) plot (Fig. 8b) has also been constructed by using the data of Fig. 7 . The intercept on the abscissa gives the maximum amount of prolactin bound, which is 26fmol/450pg of protein (57.8fmol/ mg of protein), a value similar to that obtained from the Lineweaver-Burk plot. The reciprocal of the slope yields Kd, the dissociation constant, which is 3.4x 10-10M, identical with the K. value obtained by the Lineweaver-Burk plot. The association constant, Ka, is therefore 2.94x 109M-1.
Other kinetic studies
The binding data of Fig. 2 [hormone-receptor complex] However, we find that our data do not fit the irreversible second-order reaction equation (Maron & Prutton, 1965) as they appeared to do in the case ofthe insulin-receptor interaction (Cuatrecasas, 1971a) . On the other hand, on substituting the experimental points along the curves in Fig. 2 (fmol) l25l-labelled prolactin used per tube labelled ovine prolactin binding capacity, in fmol, for the amount of membrane protein used (450pg). a reversible second-order reaction (Fig. 9) (Maron & Prutton, 1965 ) constant values of k+1 and linear plots are obtained at both temperatures studied. The average k+1 value at 37°C (5.6x1010mol-1 min'1) is more than twice that at 23°C (2.6x 10'0moPl'-min-1).
Properties ofprolactinpreviously exposedandbound to receptor Data presented in Table 2 show that the 1251_ labelled ovine prolactin recovered from the incubation medium after a 6h incubation at 23°C and the 125I-labelled ovine prolactin eluted from receptor particles are indistinguishable from fresh 1251_ labelled ovine prolactin in terms of the parameters tested. These results demonstrate that incubation of the hormone with membrane particles and the formation of hormone-receptor complex do not result in a major alteration or destruction of the hormone.
Effect of enzyme treatments on membrane receptor activity
Brief exposure of receptor particles to trypsin (50,ug/ml) resulted in a 60% decrease of the binding of 125I-labelled ovine prolactin ( Table 3 ), suggesting that protein is a functionally important part of the binding site. Phospholipase C (50,ug/ml) also leads to significant destruction of receptor activity, suggesting that phospholipids may also play a significant role in the binding of prolactin. The absence of any effect of ribonuclease, deoxyribonuclease and neuraminidase on receptor activity suggests that nucleic acids and sialic acid are not essential for the binding of prolactin to its receptor. Crude membrane protein (90mg) was incubated with 80x 106c.p.m. of 1251-labelled ovine prolactin under conditions identical with those for determination of specific binding. After 6h incubation at 23°C, the membrane particles were centrifuged at 30000g for 20min at 4°C. The supernatant was filtered through a Millipore filter (type EGWP, pore size 0.2,um). The filtrate containing the 1251-labelled ovine prolactin that had been exposed to the membrane fraction was subjected to the tests listed in the Table. The pellet was washed with three successive washings of ice-cold buffer (containing 0.1% bovine serum albumin); each step was followed by centrifugation. The pellet obtained after the final washing was resuspended in 3 ml of 0.01 M-NaOH, pH 12.5, containing 0.5% bovine serum albumin. We observed that '251-labelled ovine prolactin precipitates from solution at acid pH under the incubation conditions used; therefore acid cannot be used for dissociation. Exposure to the alkali was brief (about 2min) and the suspension was centrifuged at 30000g for 0min at 40C. The pH ofthe supematant was quickly adjusted to 7.6 with dilute HCl. The neutralized material was filtered through a Millipore filter (same type as above) and the filtrate, containing the 125I-labelled ovine prolactin eluted from the membrane particles, was tested. The amount of '2-1-labelled ovine prolactin that could be eluted by these conditions was about 45%. Determination of specific binding is described In Effects of low-molecular-weight compounds Various low-molecular-weight compounds that are frequently found in physiological fluids were incubated with the prolactin-binding fractions and specific binding of 125I-labelled ovine prolactin was determined. Compounds tested at concentrations of 0.01, 0.1, 1.0 and 10,ug/ml (concentrations range from physiological to pharmacological) include: steroid hormones, namely, oestrone, 17f,-oestradiol, oestriol, testosterone, progesterone and cortisol; nucleotides, including dibutyryl cyclic AMP (6-N-2'-O-dibutyryladenosine 3': 5'-cyclic monophosphate), cyclic AMP, cyclic GMP and the mono-, di-and tri-phosphates of adenosine, cytidine, guanosine and uridine; and other compounds such as GSH, creatine phosphate, the releasing hormone, thyrotrophin-releasing hormone, which is capable of stimulating prolactin release from the pituitary in man (Bowers et al., 1971) , and the drug, 2-bromo-a-ergocryptine (CB-154), which has been shown to inhibit prolactin secretion in vitro (Pasteels et al., 1971) and in vivo (del Pozo et al., 1972) . All these compounds have no effect on the binding of prolactin to receptors.
Distribution ofprolactin receptor activity in subcellular fractions obtained from mammary-gland homogenate Subcellular fractions obtained by centrifugation of the mammary-gland homogenate prepared as described above were tested for specific binding of '25I-labelled prolactin. The highest binding per mg of protein was observed for the 'purified' plasma-membrane material (Table 4 ). The crude postmitochondrial material (1000OOg pellet) also contains substantial binding capacity (76% of total). The binding activity observed in this fraction is probably due to the presenceofappreciableamounts offragmented plasma membranes, because the 5'-nucleotidase activity of this fraction is 0.0055 unit/mg, compared with 0.0039 unit/mg for the original tissue homogenate.
Further, on refractionation of the total microsomal material by centrifugation on a discontinuous sucrose gradient between 0.3M-and 1.58M-sucrose, the material recovered at the interphase, which has a 5'-nucleotidase activity of 0.0073 unit/mg, also contains prolactin-binding activity. These observations suggest that fragments of plasma membranes in the original microsomal pellet are responsible for the binding of prolactin, and not the ribosomes or other contaminating subcellular particles found in the same fraction. Table 4 . Distribution of 125I-labelled ovine prolactin-binding activities in subcellular particles isolated from homogenate of rabbit mammary gland Homogenization conditions and procedures for isolating subcellular particles and the determination of protein and specific binding of 125I-labelled ovine prolactin are described in the Materials and Methods section. Nuclear pellet refers to the material recovered in the bottom of the tube after sucrose-gradient centrifugation of the 1500 g material. The binding activity in the 'nuclear' pellet is probably due to intact epithelial cells, as the latter were observed by light-microscopy. The mitochondrial pellet (15000g) contains essentially no binding activity.
Prolactin-binding activity in other organs of the pregnant rabbit
In view of the diverse actions of prolactin (Nicoll & Bern, 1972) , we have examined the binding of 1251_ labelled ovine prolactin to crude membrane fractions obtained from a number oforgans. Table 5 shows that the adrenal, surprisingly, has the highest prolactin binding per mg of membrane protein. The ovary, liver and kidney also contain appreciable amounts of prolactin-binding activity. Other tissues tested do not exhibit significant binding of prolactin.
Discussion
Several recent studies have measured the binding of polypeptide hormones, such as adrenocorticotrophic hormone (Lefkowitz et al., 1970) , glucagon (Rodbell et al., 1971) , insulin (Cuatrecasas, 1971a,b; Freychet et al., 1971) , gonadotrophins (Catt et al., 1972; Kammerman et al., 1972; Lee et al., 1973) , growth hormone (Lesniak et al., 1973; Tsushima & Friesen, 1973) , thyroid-stimulating hormone (Amir et al., 1973) , calcitonin (Marx et al., 1972) and oxytocin (Soloff et al., 1972) , to various membrane fractions of tissue homogenates and intact cells. All these studies suggest that the binding of hormones to a biologically Vol. 140 significant site on plasma membranes is perhaps the first step in hormone action. The membrane structure which bind hormone are operationally termed 'receptors'.
The direct action of prolactin on mammary gland has been well documented (Cowie & Tindal, 1971 ). The present study demonstrates that receptors capable of binding prolactin are present in plasma-membrane-containing fractions isolated from the rabbit mammary gland. It would be very helpful to be able to correlate the binding of prolactin with other important biochemical actions of prolactin. In view of the important role of cyclic AMP in hormone action, the identification of an interaction between prolactin receptor and the adenylate cyclase system may substantiate the role of receptors in the action of prolactin.
Despite the lack of evidence for biochemical changes in plasma membranes secondary to the binding of prolactin, we believe that the binding of prolactin is specific. We have previously demonstrated that two hormones other than prolactin, namely human growth hormone and human placental lactogen, which are equipotent with prolactin in the rabbit in studies in vivo and in vitro, are the only hormones that are capable of competing with 125I-labelled prolactin for the receptor site (Shiu et al., 1973) . On the other hand, growth hormones from other species, which cannot compete for the prolactin receptors in our membrane fractions, are also not lactogenic in the rabbit (Cowie & Tindal, 1971; Forsyth et al., 1965; Forsyth & Folley, 1970; Forsyth, 1972; Frantz et al., 1972a,b; Barnawell, 1965; Jones & Cowie, 1972) . The finding that '25I-labelled ovine prolactin is accumulated by the rabbit mammary gland in vivo (Birkinshaw & Falconer, 1972) further suggests that the binding of prolactin to membranes in vitro is not an artifact. These results strongly support the notion that binding of prolactin to membrane receptor is a significant physiological event in the action of prolactin.
Similar to the binding of many other hormones to their receptors, the binding of 1251-labelled prolactin to its receptor is a reversible process that is time-and temperature-dependent (Figs. 2 and 9) . The slow rate of binding of prolactin suggests that the association between the hormone and the receptor is a diffusioncontrolled process, particularly in view of the extraordinary size of the diffusing species. The slow dissociation rate of prolactin from its receptor observed in this study is consistent with the study in vivo by Birkinshaw & Falconer (1972) , which demonstrated that 125I-labelled prolactin disappeared from the rabbit mammary gland with an average half-life of 52h.
The better binding of 125I-labelled prolactin prepared by the enzymic iodination to receptors, as compared with that obtained by the Hunter & Greenwood (1962) procedure (Fig. 4) , further supports the notion that only biologically active hormones bind to receptors. Our data are consistent with those of Frantz & Turkington (1972) , who showed that 125I-labelled prolactin obtained by the enzymic iodination procedure binds much better to membrane receptors isolated from mouse mammary glands and that this preparation of labelled hormone has retained 60 % of its biological activity as compared with 0.7 % for the labelled hormone prepared by the chloramine-T procedure.
Prolactin-receptor formation is not immediately followed by degradation of the labelled hormone ( Table 2 ), suggesting that the binding observed is not the result of binding to proteolytic enzymes that inactivate the hormone. The relative ease with which bound prolactin can be eluted from its receptor also suggests that binding does not involve formation of covalent bonds. The 1251-labelled prolactin, which was eluted from the membrane receptors and which was again used for binding studies, proved to bind as well in the second test as in the first, providing further evidence for the integrity of the iodinated hormone and for the lack of any major degradation of hormones after binding had occurred.
Destruction of receptor activity by treatments with trypsin and phospholipase C (Table 3) indicates that protein and phospholipid constituents are structural components that are essential for receptor activity. The lack of any effect on prolactin binding by steroid hormones, nucleotides and other low-molecularweight compounds suggest that these substances do not play any significant role in the formation of the hormone-receptor complex.
As in other studies on the binding of polypeptide hormones, subcellular fractions that contain prolactin-binding activity also possess 5'-nucleotidase activity. Since Keenan et al. (1970 Keenan et al. ( , 1972 have demonstrated that 5'-nucleotidase is a valid marker enzyme for plasma membrane of the mammary gland, the abundance of 5'-nucleotidase activity in the postmitochondrial particles indicates that this fraction contains fragmented plasma membranes, presumably as a result of the homogenization conditions used for this relatively tough tissue. It is therefore reasonable to assume that the prolactin receptors that we observe are located on cell surface membranes.
The presence of specific prolactin-binding sites in membrane fractions isolated from organs other than the mammary gland is not surprising in view of the many diverse actions of prolactin. Indeed, Nicoll & Bern (1972) have listed over 80 actions of prolactin in a large number of organs and tissues in many species. It is not known whether the high degree of binding of prolactin by the adrenal is due to the presence of more receptors, or whether the adrenal receptors have a higher affinity for prolactin. Alternatively, the homogenizing procedure that was used may have resulted in a better yield of plasma membranes from the adrenal gland than from other tissues. The stimulation of thymidine kinase and thymidylate kinase activities in rat adrenocarcinomas by injections of prolactin (Thomson et al., 1973) and the ability of prolactin to restore corticosterone biosynthesis in adrenals from hypophysectomized rats (Lis et al., 1973) certainly suggest that the adrenal is a possible target for prolactin, and the potential significance of prolactin receptors in this organ becomes quite obvious. The luteotrophic role of prolactin and the effects ofprolactin on kidney function (Nicoll & Bern, 1972) suggest that the binding of prolactin to the ovary and kidney may be physiologically significant.
The present studies indicate that membrane fractions derived from the rabbit mammary gland possess biologically significant receptors for prolactin. They provide yet another example of polypeptidehormone interaction with its target tissue. They also set forth procedures that will prove useful for the further characterization and isolation of prolactin receptors.
